<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-topiramate.xml</id>
  <title>Recalls Watch: Topiramate</title>
  <link rel="self" href="https://recalls.watch/feed/substance-topiramate.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-09-09T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99767/</id>
    <title>Supernus Pharmaceuticals, Inc.: Trokendi XR</title>
    <link href="https://recalls.watch/recall/fda/99767/"/>
    <updated>2026-09-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed dissolution specifications.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99375/</id>
    <title>Supernus Pharmaceuticals, Inc.: Trokendi XR</title>
    <link href="https://recalls.watch/recall/fda/99375/"/>
    <updated>2026-07-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93552/</id>
    <title>Azurity Pharmaceuticals, Inc.: Eprontia</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93552"/>
    <updated>2024-01-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.</summary>
  </entry>
</feed>
